Human mesenchymal stem cells may be involved in keloid pathogenesis.
スポンサーリンク
概要
- 論文の詳細を見る
BACKGROUND: The pathogenesis of keloid is poorly understood. Although vigorous investigations have attempted to elucidate the mechanisms or causative factors of keloid, there are little data on why keloids are very intractable and recur easily in each patient. METHODS: In an attempt to analyze the possible interaction between human mesenchymal stem cells and keloid-derived fibroblasts, the dual-chamber cell-migration assay, cell proliferation, ultrastructural morphology, and Western blot analysis were used to investigate the production of the extracellular matrices of the coculture. RESULTS: Cell proliferation was not significantly different between keloid-derived fibroblasts and normal dermal fibroblasts during a 4-day observation period. There was a significant cell migration of human mesenchymal stem cells when keloid-derived fibroblasts were placed in the bottom chamber, compared to when normal dermal fibroblasts were placed in the same way in 8-microm diameter pore membranes (190.6 +/- 51.45 and 32.0 +/- 6.20 cells/field, respectively, P < 0.01). With 3-microm diameter pores, the human mesenchymal stem cells migrated in the pores only when the keloid-derived fibroblasts were placed in the bottom chambers (6.4 +/- 3.84 cells/field). Monolayer coculture of human mesenchymal stem cells and keloid-derived fibroblasts demonstrated further functional differentiation, such as collagen secretion and abundant rough endoplasmic reticulum. Western blot analysis of the cells in the modified dual-chamber culture demonstrated most significantly abundant fibronectin expression when the human mesenchymal stem cells contained keloid fibroblasts. CONCLUSION: The results of this study may indicate that human mesenchymal stem cells participate and recruit in keloid pathogenesis by differentiating themselves toward keloid recalcitrant formation and progression.
論文 | ランダム
- バイオ産業と生物多様性条約解説シリーズ(2)植物遺伝資源を用いる医薬品探索研究の現状
- バイオ産業と生物多様性条約解説シリーズ(1)生物多様性条約の課題とバイオ産業
- フランス簡易株式組織会社(SAS)における株式譲渡に関する定款自治の拡大と限界(2・完)
- 元SAS精鋭に守られていた「ベッカム」 (日本は大善戦! テレビに映らなかった「ワールドカップ」異聞)
- 18号監査、SAS70等信頼性評価は? クラウドをめぐるIT内部統制 (ユーザー企業のセキュリティは万全か クラウド統制の考え方・つくり方)